The current coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a major public health crisis …

The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …

Background Preliminary data suggest that COVID-19 has reduced access to solid organ
transplantation. However, the global consequences of the COVID-19 pandemic on …

Background Chronic kidney disease (CKD) and immunosuppression, such as in renal
transplantation (RT), stand as one of the established potential risk factors for severe …

Rationale: Elexacaftor–tezacaftor–ivacaftor is a CFTR (cystic fibrosis [CF] transmembrane
conductance regulator) modulator combination, developed for patients with CF with at least …

Background The COVID-19 pandemic has severely affected health systems and medical
research worldwide but its impact on the global publication dynamics and non-COVID-19 …

Current short-term kidney post–transplant survival rates are excellent, but longer-term
outcomes have historically been unchanged. This study used data from the national …

Patients waitlisted for and recipients of solid organ transplants (SOT) are perceived to have
a higher risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

We describe a case of proven transmission of SARS‐CoV‐2 from lung donor to recipient.
The donor had no clinical history or findings suggestive of infection with SARS‐CoV‐2 and …

Background. The clinical effectiveness of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in immunosuppressed solid organ and islet …